BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 18829437)

  • 1. Single-particle kinetics of influenza virus membrane fusion.
    Floyd DL; Ragains JR; Skehel JJ; Harrison SC; van Oijen AM
    Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15382-7. PubMed ID: 18829437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method for measurement of viral fusion kinetics at the single particle level.
    Floyd DL; Harrison SC; van Oijen AM
    J Vis Exp; 2009 Sep; (31):. PubMed ID: 19736545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anionic lipids are required for vesicular stomatitis virus G protein-mediated single particle fusion with supported lipid bilayers.
    Matos PM; Marin M; Ahn B; Lam W; Santos NC; Melikyan GB
    J Biol Chem; 2013 May; 288(18):12416-25. PubMed ID: 23493401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza Hemifusion Phenotype Depends on Membrane Context: Differences in Cell-Cell and Virus-Cell Fusion.
    Zawada KE; Okamoto K; Kasson PM
    J Mol Biol; 2018 Mar; 430(5):594-601. PubMed ID: 29355500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-virus content-mixing assay reveals cholesterol-enhanced influenza membrane fusion efficiency.
    Liu KN; Boxer SG
    Biophys J; 2021 Nov; 120(21):4832-4841. PubMed ID: 34536389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza-virus membrane fusion by cooperative fold-back of stochastically induced hemagglutinin intermediates.
    Ivanovic T; Choi JL; Whelan SP; van Oijen AM; Harrison SC
    Elife; 2013 Feb; 2():e00333. PubMed ID: 23550179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFITM3 blocks influenza virus entry by sorting lipids and stabilizing hemifusion.
    Klein S; Golani G; Lolicato F; Lahr C; Beyer D; Herrmann A; Wachsmuth-Melm M; Reddmann N; Brecht R; Hosseinzadeh M; Kolovou A; Makroczyova J; Peterl S; Schorb M; Schwab Y; Brügger B; Nickel W; Schwarz US; Chlanda P
    Cell Host Microbe; 2023 Apr; 31(4):616-633.e20. PubMed ID: 37003257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.
    Desai TM; Marin M; Chin CR; Savidis G; Brass AL; Melikyan GB
    PLoS Pathog; 2014 Apr; 10(4):e1004048. PubMed ID: 24699674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level.
    Otterstrom JJ; Brandenburg B; Koldijk MH; Juraszek J; Tang C; Mashaghi S; Kwaks T; Goudsmit J; Vogels R; Friesen RH; van Oijen AM
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):E5143-8. PubMed ID: 25404330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reevaluating herpes simplex virus hemifusion.
    Jackson JO; Longnecker R
    J Virol; 2010 Nov; 84(22):11814-21. PubMed ID: 20844038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disentangling Viral Membrane Fusion from Receptor Binding Using Synthetic DNA-Lipid Conjugates.
    Rawle RJ; Boxer SG; Kasson PM
    Biophys J; 2016 Jul; 111(1):123-31. PubMed ID: 27410740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanisms of lipid-protein rearrangements during viral infection.
    Chizmadzhev YA
    Bioelectrochemistry; 2004 Jun; 63(1-2):129-36. PubMed ID: 15110263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging multiple intermediates of single-virus membrane fusion mediated by distinct fusion proteins.
    Joo KI; Tai A; Lee CL; Wong C; Wang P
    Microsc Res Tech; 2010 Sep; 73(9):886-900. PubMed ID: 20232362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of Influenza Virus Envelope's Fusogenicity by Viral Fusion Inhibitors.
    Rowse M; Qiu S; Tsao J; Yamauchi Y; Wang G; Luo M
    ACS Infect Dis; 2016 Jan; 2(1):47-53. PubMed ID: 27622947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Developments in Single-Virus Fusion Assay.
    Haldar S
    J Membr Biol; 2022 Dec; 255(6):747-755. PubMed ID: 36173449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation.
    Chernomordik LV; Frolov VA; Leikina E; Bronk P; Zimmerberg J
    J Cell Biol; 1998 Mar; 140(6):1369-82. PubMed ID: 9508770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization and Sequencing of Membrane Remodeling Leading to Influenza Virus Fusion.
    Gui L; Ebner JL; Mileant A; Williams JA; Lee KK
    J Virol; 2016 Aug; 90(15):6948-6962. PubMed ID: 27226364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Architecture of a nascent viral fusion pore.
    Lee KK
    EMBO J; 2010 Apr; 29(7):1299-311. PubMed ID: 20168302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemagglutinin fusion peptide mutants in model membranes: structural properties, membrane physical properties, and PEG-mediated fusion.
    Haque ME; Chakraborty H; Koklic T; Komatsu H; Axelsen PH; Lentz BR
    Biophys J; 2011 Sep; 101(5):1095-104. PubMed ID: 21889446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delay time for influenza virus hemagglutinin-induced membrane fusion depends on hemagglutinin surface density.
    Clague MJ; Schoch C; Blumenthal R
    J Virol; 1991 May; 65(5):2402-7. PubMed ID: 1850019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.